- Home
- LNTH vs MIR Comparison
LNTH vs MIR Comparison
Compare LNTH & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- MIR
- Stock Information
- Founded
- LNTH 1956
- MIR 2005
- Country
- LNTH United States
- MIR United States
- Employees
- LNTH N/A
- MIR N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- MIR Industrial Machinery/Components
- Sector
- LNTH Health Care
- MIR Technology
- Exchange
- LNTH Nasdaq
- MIR Nasdaq
- Market Cap
- LNTH 5.7B
- MIR 5.0B
- IPO Year
- LNTH 2015
- MIR N/A
- Fundamental
- Price
- LNTH $81.47
- MIR $20.62
- Analyst Decision
- LNTH Strong Buy
- MIR Strong Buy
- Analyst Count
- LNTH 5
- MIR 4
- Target Price
- LNTH $131.20
- MIR $19.25
- AVG Volume (30 Days)
- LNTH 932.7K
- MIR 3.5M
- Earning Date
- LNTH 07-30-2025
- MIR 07-31-2025
- Dividend Yield
- LNTH N/A
- MIR N/A
- EPS Growth
- LNTH N/A
- MIR N/A
- EPS
- LNTH 3.53
- MIR N/A
- Revenue
- LNTH $1,536,699,000.00
- MIR $870,200,000.00
- Revenue This Year
- LNTH $4.63
- MIR $6.45
- Revenue Next Year
- LNTH $9.35
- MIR $7.51
- P/E Ratio
- LNTH $23.03
- MIR N/A
- Revenue Growth
- LNTH 12.53
- MIR 7.25
- 52 Week Low
- LNTH $73.11
- MIR $9.11
- 52 Week High
- LNTH $126.89
- MIR $22.21
- Technical
- Relative Strength Index (RSI)
- LNTH 50.75
- MIR 55.14
- Support Level
- LNTH $78.74
- MIR $20.14
- Resistance Level
- LNTH $85.31
- MIR $20.96
- Average True Range (ATR)
- LNTH 2.28
- MIR 0.74
- MACD
- LNTH 0.51
- MIR -0.16
- Stochastic Oscillator
- LNTH 45.38
- MIR 43.64
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About MIR Mirion Technologies Inc.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.